Table 5.
Effect of Glycosaminoglycan on Oral Glucose Tolerance in Diabetic Mice (Mean±SD)
| Group | 0 min | 30 min | 60 min | 120 min | AUG |
|---|---|---|---|---|---|
| Normal | 5.82±0.47 | 7.54±0.73 | 8.42±0.63 | 6.85±0.85 | 14.96±1.26 |
| Model control | 19.03±3.49** | 25.05±2.35** | 31.03±3.30** | 22.05±2.49** | 51.27±3.90** |
| Metformin hydrochloride | 11.87±2.62aa | 22.86±3.28 | 17.95±2.68aa | 13.36±3.09aa | 34.54±5.72aa |
| GAG-1 | 14.10±2.40aa | 21.08±2.51a | 26.83±3.67a | 16.97±3.34a | 42.67±6.22a |
| GAG-2 | 12.92±2.54aa | 24.00±2.90 | 19.06±2.44aa | 14.88±2.84aa | 36.92±4.46aa |
| GAG-3 | 11.96±2.24aa | 23.07±2.82 | 17.90±1.90aa | 13.93±2.67aa | 34.91±4.56aa |
**
P<.01 as the model control group compared with the normal group; aP<.05, aaP<.01 as compared to the model control group.